(Date:11/6/2009)...ire/ -- Calbiotech, Inc. announced today that it h...ch (SBIR) Phase I contract by the U.S. Army Medica...e agreement, Calbiotech will develop analyte speci...rus. ,, Dengue virus is a mosquito-born flav...forces deployed to tropical areas of the world. Du...
(Date:11/5/2009)...FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today ...ter ended September 30, 2009. GenVec reported a ne...hree months ended September 30, 2009 compared to a... comparable quarter of 2008. For the nine months e....1 million ($0.15 per share), compared to a net lo...
(Date:11/5/2009)...5, 2009 at 4:30 p.m. Eastern Time , BOTHELL, ...ncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the...ted financial results for the third quarter and ni...e Company,s highlights for the third quarter of 20...ct the operations of OncoGenex Technologies Inc. (...
(Date:11/5/2009)...swire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX )...eptor-based technologies to discover novel flavor ... supply industries, today provided a corporate upd...uarter ended September 30, 2009. Revenues were $4... to $4.0 million for the third quarter of 2008, an...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14...fe Sciences,announced today that Richard Evans has...sibility will be providing advisory services to co... as well as selected investment,assignments in cap...ted,drug analyst, he will also have responsibility... in the capital markets area. "Richard brings us ...
... Presentations Accepted to Meeting, CAMBRIDGE, Ma...oday announced that 23 presentations will showcase...ts antibiotic drug discovery,platform at the upcom...robial Agents and Chemotherapy (ICAAC), taking pla... Ph.D., Chief Scientific Officer of Targanta Thera...
...al Partners and Versant Ventures Lead ...DISON, Wis., Sept. 12 OpGen, Inc., today announce...ity financing. The round,was led by CHL Medical Pa...ures, with previous investor Mason Wells also part...ecome chairman of the Board of,Directors and will ...
Other Biology Technology:Senior Research Analyst Richard Evans Joins AVOS Life Sciences 2Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 2Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 3Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 4Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 5Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 6Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 7OpGen Announces $23.6 Million Series A Financing 2OpGen Announces $23.6 Million Series A Financing 3... the University of Wisconsin-Madison is using musi... species in the state. , "Research shows music ...g memory, emotion, attitudes, and even behavior," ...es communication at UW-Madison and environmental c...w, who directed the project, recruited a group of ...
...008 SRI International announced today that it has ...s grant from the Bill & Melinda Gates Foundation. ...h research project conducted by Krishna Kodukula, ...enter for Advanced Drug Research (CADRE) in Shenan...ociate director of Proteomics and Protein Biochemi...
...he University of Houston to use technologies with ...tools that will help doctors and technicians bette...d neck cancer. , Dr. Ali Kamrani, founding direct...ory at UH and a former auto industry researcher, i...r and deputy research director of radiation physic...
Other Biology News:SRI International receives $100,000 Grand Challenges Explorations grant 2From cars to cancer: UH professor employs auto industry tools for tumor therapy 2From cars to cancer: UH professor employs auto industry tools for tumor therapy 3From cars to cancer: UH professor employs auto industry tools for tumor therapy 4...nd scales with RS232 ports and sends that data tra... the weight into the program, BalanceTalk can auto...rser extracts required data , Add date/time stamps...timed intervals , Keyboard macros automate cursor ...
Rabbit Anti-Human Prolactin Releasing Hormone Receptor (GPR10) Polyclonal Antibody, Unconjugated from IMGENEX
...ection and automation that is controlled from with...cel , Pre-configured library of interfaces for ba...es can be added and configured by the user , Col...eet , Allows for multi-tasking during data colle...
ReBlot™ Plus Strong Antibody Stripping Solution, 10x from Upstate
Biology Products: